162 related articles for article (PubMed ID: 6787171)
1. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
Bailey R; Crisp E; Jackson DM; Jenkins O
J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171
[TBL] [Abstract][Full Text] [Related]
2. Subacute L-DOPA in mice: biochemical and behavioural effects.
Jenkins O; Bailey R; Crisp E; Jackson DM
Psychopharmacology (Berl); 1980; 68(1):77-83. PubMed ID: 6771801
[TBL] [Abstract][Full Text] [Related]
3. Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.
Jackson DM; Jenkins OF; Malor R; Christie MJ; Gregory P
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):271-4. PubMed ID: 6686648
[TBL] [Abstract][Full Text] [Related]
4. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
Jackson DM; Walters JR; Miller LP
Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029
[TBL] [Abstract][Full Text] [Related]
5. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
[TBL] [Abstract][Full Text] [Related]
6. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
Strömbom U
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
[TBL] [Abstract][Full Text] [Related]
7. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
Dunstan R; Jackson DM
Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
[TBL] [Abstract][Full Text] [Related]
8. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
Fayle P; Jackson DM; Jenkins OF; Lafferty PA
Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
[TBL] [Abstract][Full Text] [Related]
9. Behavioural and biochemical effects of subchronic treatment with raclopride in the rat: tolerance and brain monoamine receptor sensitivity.
Ahlenius S; Ericson EL; Högberg K; Wijkström A
Pharmacol Toxicol; 1991 Apr; 68(4):302-9. PubMed ID: 1907738
[TBL] [Abstract][Full Text] [Related]
10. [Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)].
Shoji T; Tadano T; Kisara K
Nihon Yakurigaku Zasshi; 1977 May; 73(4):371-8. PubMed ID: 908541
[TBL] [Abstract][Full Text] [Related]
11. An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice.
Archer T; Fredriksson A
J Neural Transm (Vienna); 2003 Feb; 110(2):183-200. PubMed ID: 12589577
[TBL] [Abstract][Full Text] [Related]
12. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists.
Strömbom U; Svensson TH; Carlsson A
Psychopharmacology (Berl); 1977 Mar; 51(3):293-9. PubMed ID: 403547
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
Ponzio F; Cimino M; Achilli G; Lipartiti M; Perego C; Vantini G; Algeri S
Life Sci; 1984 May; 34(22):2107-16. PubMed ID: 6145075
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
[TBL] [Abstract][Full Text] [Related]
16. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
Dunstan R; Jackson DM
Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762
[TBL] [Abstract][Full Text] [Related]
17. Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
Kuschinsky K
Psychopharmacologia; 1975 Jun; 42(3):225-9. PubMed ID: 1172252
[TBL] [Abstract][Full Text] [Related]
18. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
Jackson D; Carlsson A; Hjorth S; Lindberg P
J Neural Transm; 1982; 53(4):233-45. PubMed ID: 6286867
[TBL] [Abstract][Full Text] [Related]
19. Locomotor activity and dopamine synthesis following 1 and 15 days of withdrawal from repeated apomorphine treatments.
Rowlett JK; Mattingly BA; Bardo MT
Pharmacol Biochem Behav; 1997; 57(1-2):13-8. PubMed ID: 9164548
[TBL] [Abstract][Full Text] [Related]
20. The role of dopamine in the expression of morphine withdrawal.
el-Kadi AO; Sharif SI
Gen Pharmacol; 1998 Apr; 30(4):499-505. PubMed ID: 9522166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
